{"id":2520,"date":"2024-02-29T18:35:40","date_gmt":"2024-02-29T18:35:40","guid":{"rendered":"https:\/\/ingeneron.com\/home-new-2\/"},"modified":"2025-05-14T17:40:46","modified_gmt":"2025-05-14T17:40:46","slug":"home-new-2","status":"publish","type":"page","link":"https:\/\/ingeneron.com\/de\/","title":{"rendered":"Home"},"content":{"rendered":"<p>InGeneron\u2019s Transpose Ultra<span style=\"font-size: 14pt;\"><sup>\u00ae<\/sup><\/span>\u00a0cell therapy platform consists of a processing unit, a set of disposables, and Matrase\u2122, a proprietary enzyme mixture. The platform allows the isolation of regenerative cells from the patients&#8216; own adipose tissue at point-of-care in less than 90 minutes for same-day treatment. The cells are re-administered into the patient\u2019s damaged tissue by injection under ultrasound or fluoroscopic guidance.<\/p>\n<p>The Transpose Ultra<span style=\"font-size: 14pt;\"><sup>\u00ae<\/sup><\/span>\u00a0System is being investigated in several FDA-approved clinical trials and is currently available in the U.S. for research use only. More information on InGeneron\u2019s actively enrolling clinical trials can be found at www.clinicaltrials.gov under the identifiers NCT03752827, NCT03513731, and NCT03503305. InGeneron is a clinical-stage biotechnology company developing novel, safe, and evidence-based cell therapies. We are setting new therapeutic standards by enabling minimally invasive treatments that unlock the healing potential of each patient\u2019s own regenerative cells processed at the point of care for same-day treatment. We currently focus on helping patients impacted by orthopedic conditions and are conducting several clinical trials to validate our technology as a disease-modifying treatment. Based on more than 20 years of research, InGeneron is dedicated to developing therapies supported by clinical evidence and approved by the FDA.https:\/\/ingeneron.com\/wp-admin\/edit.php?post_type=page<\/p>\n","protected":false},"excerpt":{"rendered":"<p>InGeneron\u2019s Transpose Ultra\u00ae\u00a0cell therapy platform consists of a processing unit, a set of disposables, and Matrase\u2122, a proprietary enzyme mixture. The platform allows the isolation of regenerative cells from the patients&#8216; own adipose tissue at point-of-care in less than 90 minutes for same-day treatment. The cells are re-administered into the patient\u2019s damaged tissue by injection [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":190,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"tpl-home.php","meta":{"om_disable_all_campaigns":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-2520","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Entwicklung zellbasierter Therapien - InGeneron<\/title>\n<meta name=\"description\" content=\"InGeneron ist ein Biotechnologieunternehmen im klinischen Stadium, das zellbasierte Therapien f\u00fcr die Orthop\u00e4die entwickelt.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ingeneron.com\/de\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Entwicklung zellbasierter Therapien - InGeneron\" \/>\n<meta property=\"og:description\" content=\"InGeneron ist ein Biotechnologieunternehmen im klinischen Stadium, das zellbasierte Therapien f\u00fcr die Orthop\u00e4die entwickelt.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ingeneron.com\/de\/\" \/>\n<meta property=\"og:site_name\" content=\"InGeneron\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-14T17:40:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ingeneron.com\/wp-content\/uploads\/2022\/06\/Group-381.png\" \/>\n\t<meta property=\"og:image:width\" content=\"590\" \/>\n\t<meta property=\"og:image:height\" content=\"575\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/ingeneron.com\/wp-content\/uploads\/2022\/10\/pic-e1665679425308.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/ingeneron.com\\\/de\\\/\",\"url\":\"https:\\\/\\\/ingeneron.com\\\/de\\\/\",\"name\":\"Entwicklung zellbasierter Therapien - InGeneron\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ingeneron.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ingeneron.com\\\/de\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ingeneron.com\\\/de\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ingeneron.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Rectangle-115.jpg\",\"datePublished\":\"2024-02-29T18:35:40+00:00\",\"dateModified\":\"2025-05-14T17:40:46+00:00\",\"description\":\"InGeneron ist ein Biotechnologieunternehmen im klinischen Stadium, das zellbasierte Therapien f\u00fcr die Orthop\u00e4die entwickelt.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ingeneron.com\\\/de\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ingeneron.com\\\/de\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/ingeneron.com\\\/de\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ingeneron.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Rectangle-115.jpg\",\"contentUrl\":\"https:\\\/\\\/ingeneron.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Rectangle-115.jpg\",\"width\":1920,\"height\":828,\"caption\":\"Patients treated by cell-based therapies running\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ingeneron.com\\\/de\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ingeneron.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ingeneron.com\\\/#website\",\"url\":\"https:\\\/\\\/ingeneron.com\\\/\",\"name\":\"InGeneron\",\"description\":\"Innovating Regenerative Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/ingeneron.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ingeneron.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ingeneron.com\\\/#organization\",\"name\":\"InGeneron\",\"url\":\"https:\\\/\\\/ingeneron.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/ingeneron.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ingeneron.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/ingeneron.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo.png\",\"width\":183,\"height\":69,\"caption\":\"InGeneron\"},\"image\":{\"@id\":\"https:\\\/\\\/ingeneron.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Entwicklung zellbasierter Therapien - InGeneron","description":"InGeneron ist ein Biotechnologieunternehmen im klinischen Stadium, das zellbasierte Therapien f\u00fcr die Orthop\u00e4die entwickelt.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ingeneron.com\/de\/","og_locale":"de_DE","og_type":"article","og_title":"Entwicklung zellbasierter Therapien - InGeneron","og_description":"InGeneron ist ein Biotechnologieunternehmen im klinischen Stadium, das zellbasierte Therapien f\u00fcr die Orthop\u00e4die entwickelt.","og_url":"https:\/\/ingeneron.com\/de\/","og_site_name":"InGeneron","article_modified_time":"2025-05-14T17:40:46+00:00","og_image":[{"width":590,"height":575,"url":"https:\/\/ingeneron.com\/wp-content\/uploads\/2022\/06\/Group-381.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_image":"https:\/\/ingeneron.com\/wp-content\/uploads\/2022\/10\/pic-e1665679425308.jpg","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/ingeneron.com\/de\/","url":"https:\/\/ingeneron.com\/de\/","name":"Entwicklung zellbasierter Therapien - InGeneron","isPartOf":{"@id":"https:\/\/ingeneron.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ingeneron.com\/de\/#primaryimage"},"image":{"@id":"https:\/\/ingeneron.com\/de\/#primaryimage"},"thumbnailUrl":"https:\/\/ingeneron.com\/wp-content\/uploads\/2022\/06\/Rectangle-115.jpg","datePublished":"2024-02-29T18:35:40+00:00","dateModified":"2025-05-14T17:40:46+00:00","description":"InGeneron ist ein Biotechnologieunternehmen im klinischen Stadium, das zellbasierte Therapien f\u00fcr die Orthop\u00e4die entwickelt.","breadcrumb":{"@id":"https:\/\/ingeneron.com\/de\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ingeneron.com\/de\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/ingeneron.com\/de\/#primaryimage","url":"https:\/\/ingeneron.com\/wp-content\/uploads\/2022\/06\/Rectangle-115.jpg","contentUrl":"https:\/\/ingeneron.com\/wp-content\/uploads\/2022\/06\/Rectangle-115.jpg","width":1920,"height":828,"caption":"Patients treated by cell-based therapies running"},{"@type":"BreadcrumbList","@id":"https:\/\/ingeneron.com\/de\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ingeneron.com\/de\/"},{"@type":"ListItem","position":2,"name":"Home"}]},{"@type":"WebSite","@id":"https:\/\/ingeneron.com\/#website","url":"https:\/\/ingeneron.com\/","name":"InGeneron","description":"Innovating Regenerative Medicine","publisher":{"@id":"https:\/\/ingeneron.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ingeneron.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/ingeneron.com\/#organization","name":"InGeneron","url":"https:\/\/ingeneron.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/ingeneron.com\/#\/schema\/logo\/image\/","url":"https:\/\/ingeneron.com\/wp-content\/uploads\/2022\/05\/logo.png","contentUrl":"https:\/\/ingeneron.com\/wp-content\/uploads\/2022\/05\/logo.png","width":183,"height":69,"caption":"InGeneron"},"image":{"@id":"https:\/\/ingeneron.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ingeneron.com\/de\/wp-json\/wp\/v2\/pages\/2520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ingeneron.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ingeneron.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ingeneron.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ingeneron.com\/de\/wp-json\/wp\/v2\/comments?post=2520"}],"version-history":[{"count":34,"href":"https:\/\/ingeneron.com\/de\/wp-json\/wp\/v2\/pages\/2520\/revisions"}],"predecessor-version":[{"id":2912,"href":"https:\/\/ingeneron.com\/de\/wp-json\/wp\/v2\/pages\/2520\/revisions\/2912"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ingeneron.com\/de\/wp-json\/wp\/v2\/media\/190"}],"wp:attachment":[{"href":"https:\/\/ingeneron.com\/de\/wp-json\/wp\/v2\/media?parent=2520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}